Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients
Clinical trial NCT01351636 · COMPLETED
Trial details
- NCT number
- NCT01351636
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2018-10-10
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.